PEDIATRICS Vol. 118 No. 3 September 2006, pp. 1188-1199 (doi:10.1542/peds.2005-2022)
SPECIAL ARTICLE |
Expert Committee Recommendations for Acne Management
Department of Dermatology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania
In 2003, an international committee of physicians and researchers in the field of acne, working together as the Global Alliance to Improve Outcomes in Acne, developed consensus guidelines for the treatment of acne. These guidelines were evidence based when possible but also included the extensive clinical experience of this group of international dermatologists. As a result of the evaluation of available data and the experience, significant changes occurred in the management routines for acne. The greatest change arose on the basis of improved understanding of acne pathophysiology. The recommendation now is that acne treatments should be combined to target as many pathogenic factors as possible.
- A topical retinoid should be the foundation of treatment for most patients with acne, because retinoids target the microcomedo, the precursor to all acne lesions. Retinoids also are comedolytic and have intrinsic antiinflammatory effects, thus targeting 2 pathogenic factors in acne.
- Combining a topical retinoid with an antimicrobial agent targets 3 pathogenic factors, and clinical trials have shown that comination therapy results in significantly faster and greater clearing as opposed to antimicrobial therapy alone.
- Oral antibiotics should be used only in moderate-to-severe acne, should not be used as monotherapy, and should be discontinued as soon as possible (usually within 812 weeks).
- Because of their effect on the microcomedo, topical retinoids also are recommended as an important facet of maintenance therapy.
Key Words: acne vulgaris pathophysiology retinoids antimicrobials combination therapy maintenance therapy
Abbreviations: BPObenzoyl peroxide
Accepted Apr 27, 2006.
This article has been cited by other articles:
![]() |
W. L. Tom and S. Fallon Friedlander Acne Through the Ages: Case-Based Observations Through Childhood and Adolescence Clinical Pediatrics, September 1, 2008; 47(7): 639 - 651. [Abstract] [PDF] |
||||
![]() |
H. S. Blix, A. Engeland, I. Litleskare, and M. Ronning Age- and gender-specific antibacterial prescribing in Norway J. Antimicrob. Chemother., May 1, 2007; 59(5): 971 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Newman Industry-Sponsored "Expert Committee Recommendations for Acne Management" Promote Expensive Drugs on the Basis of Weak Evidence Pediatrics, March 1, 2007; 119(3): 650 - 650. [Full Text] [PDF] |
||||
![]() |
Journal Watch Arch. Dis. Child., March 1, 2007; 92(3): 275 - 276. [Full Text] [PDF] |
||||
![]() |
The Changing Face of Acne Treatment Journal Watch Pediatrics and Adolescent Medicine, November 15, 2006; 2006(1115): 3 - 3. [Full Text] |
||||









